M. Neuberger
Papers
1
Total Citations
2
H-Index
1
About
M. Neuberger is a clinical researcher whose work centers on improving surgical outcomes in urologic oncology, particularly through innovative approaches to reducing postoperative complications. Their most notable contribution is the design and leadership of the PELYCAN study, a randomized controlled adaptive phase III trial comparing a peritoneal flap technique to standard care for preventing lymphocele formation after robotic-assisted radical prostatectomy with pelvic lymph node dissection. This work addresses a critical gap in urologic surgery, as lymphoceles are a common and morbid complication following these procedures. While the 2023 publication has garnered early citations, its significance lies in its rigorous adaptive trial methodology and potential to establish a new standard of care. Neuberger’s research demonstrates a commitment to evidence-based surgical innovation, combining technical refinement with robust clinical trial design. Their work is particularly relevant for surgeons and researchers focused on minimizing complications in minimally invasive prostate cancer surgery, and the PELYCAN study’s findings are poised to influence future guidelines and practice patterns in the field.
Research Focus
Key Achievements
Top Papers
- 1